Idiopathic Gastroparesis clinical trials at UCSD
1 research study open to eligible people
Showing trials for
Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis
open to eligible people ages 18-70
To investigate the safety and efficacy of tradipitant versus placebo in relieving nausea and other symptoms of gastroparesis.
La Jolla, California and other locations
Our lead scientists for Idiopathic Gastroparesis research studies include David Kunkel.
Last updated: